Clinical Trials

Ultra-Processed Foods Linked to Increased Psoriasis Severity
Research & Development Ultra-Processed Foods Linked to Increased Psoriasis Severity

Psoriasis is a chronic inflammatory skin disease that affects millions of people worldwide. Recent research published in JAMA Dermatology has shed light on the potential link between the consumption of ultra-processed foods (UPFs) and the severity of active psoriasis. This study suggests that diet

Innovative Technologies Revolutionize Platelet Function Assessments
Research & Development Innovative Technologies Revolutionize Platelet Function Assessments

Platelets play an essential role in human physiology, particularly during the clotting process in response to injury. Despite their importance, the comprehension and measurement of platelet functionality have consistently posed challenges for scientists and clinicians. This issue has become even

Can Biomarkers and ERPs Revolutionize Mental Healthcare by 2025?
Research & Development Can Biomarkers and ERPs Revolutionize Mental Healthcare by 2025?

Mental healthcare has long relied on subjective methods for diagnosing and treating conditions. The Diagnostic and Statistical Manual of Mental Disorders (DSM) has been the cornerstone of this approach, guiding clinicians through a polythetic diagnostic process based on observed symptoms and

Is Roche's $1B Acquisition of Poseida Shaping Cell Therapy's Future?
Research & Development Is Roche's $1B Acquisition of Poseida Shaping Cell Therapy's Future?

Roche is making a bold move in the field of allogeneic cell therapy with its recent acquisition of Poseida Therapeutics, a San Diego-based biotech firm. This $1 billion upfront deal underscores Roche's commitment to expanding its portfolio in cell and gene therapies, particularly targeting

Can Innovative Approaches Overcome Gene Therapy’s Persistent Challenges?
Research & Development Can Innovative Approaches Overcome Gene Therapy’s Persistent Challenges?

Gene therapy has made remarkable strides in recent years, with 20 approved indications in the United States and a record number of approvals in 2023. Investigational trials are rapidly increasing across various diseases, including hemophilia B, sickle cell disease, and Duchenne muscular dystrophy.

Cardiovascular Risks Lead to Early Brain Decline in Men, Study Finds
Research & Development Cardiovascular Risks Lead to Early Brain Decline in Men, Study Finds

The article "Cardiovascular disease risk linked to early brain decline in men," published in the Journal of Neurology Neurosurgery & Psychiatry, examines the correlation between cardiovascular disease risk factors and brain health decline, with a specific focus on gender differences.

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later